Positron Corporation is a nuclear medicine healthcare company specializing in the field of cardiac Positron Emission Tomography (PET) imaging. Focused exclusively on supporting cardiac PET for over 30 years, Positron is committed to minimizing the barriers of entry to make this superior modality more accessible to clinicians and patients everywhere. Recognized as the gold standard in diagnostic nuclear imaging, cardiac PET is the most effective method in nuclear cardiology for detecting coronary artery disease. Positron’s Attrius® offers the latest in cardiac PET technology and is the only choice when looking for a new dedicated PET system. Optimized for MPI, the Attrius provides excellent sensitivity with minimal radiation exposure, when compared to SPECT, and is capable of performing routine quantitative measurements. The Attrius system enables healthcare providers to more accurately diagnose heart disease, improve patient outcomes, and practice cost effective medicine. PET is the premier imaging technology for the future of nuclear cardiology making Positron and the Attrius the best choice for maximizing your practice’s capabilities and providing your patient’s with the best in cardiac care. Contact us to discover more about the Attrius, including our new financing solutions that can be customized to suit your needs.